Veterinary Vaccines Market by Technology (Toxoid, Recombinant, Inactivated), Disease (Rabies, Clostridial Diseases, Swine Pneumonia, Avian Influenza, Porcine Parvovirus), Type (Aquaculture, Poultry, Companion Animal, Porcine) – 2021 to 2026

$3,850.00$5,850.00

Published on: April 9, 2021
Clear
SKU: GMS-3204 Category:

OVERVIEW

Global Veterinary Vaccines Market is expected reach USD13.39 billion by 2026, growing at a CAGR of 7.6% during the forecast period. Prevention of infectious diseases in companion animals and livestock is the growth engine of veterinary vaccines market. The market competitors are focusing on mitigating the problems caused by COVID-19 pandemic. These include maintaining the uninterrupted supply of veterinary vaccines amid the global outbreak.

Veterinary Vaccines Market by Technology (Toxoid, Recombinant, Inactivated), Disease (Rabies, Clostridial Diseases, Swine Pneumonia, Avian Influenza, Porcine Parvovirus), Type (Aquaculture, Poultry, Companion Animal, Porcine) – 2021 to 2026 1

Veterinary Vaccines Market by Technology (Toxoid, Recombinant, Inactivated), Disease (Rabies, Clostridial Diseases, Swine Pneumonia, Avian Influenza, Porcine Parvovirus), Type (Aquaculture, Poultry, Companion Animal, Porcine) – 2021 to 2026 2

Veterinary Vaccines Market by Technology (Toxoid, Recombinant, Inactivated), Disease (Rabies, Clostridial Diseases, Swine Pneumonia, Avian Influenza, Porcine Parvovirus), Type (Aquaculture, Poultry, Companion Animal, Porcine) – 2021 to 2026 3

Veterinary Vaccines Market by Technology (Toxoid, Recombinant, Inactivated), Disease (Rabies, Clostridial Diseases, Swine Pneumonia, Avian Influenza, Porcine Parvovirus), Type (Aquaculture, Poultry, Companion Animal, Porcine) – 2021 to 2026 4

Veterinary Vaccines Market by Technology (Toxoid, Recombinant, Inactivated), Disease (Rabies, Clostridial Diseases, Swine Pneumonia, Avian Influenza, Porcine Parvovirus), Type (Aquaculture, Poultry, Companion Animal, Porcine) – 2021 to 2026 5

Veterinary Vaccines Market by Technology (Toxoid, Recombinant, Inactivated), Disease (Rabies, Clostridial Diseases, Swine Pneumonia, Avian Influenza, Porcine Parvovirus), Type (Aquaculture, Poultry, Companion Animal, Porcine) – 2021 to 2026 6

Veterinary Vaccines Market by Technology (Toxoid, Recombinant, Inactivated), Disease (Rabies, Clostridial Diseases, Swine Pneumonia, Avian Influenza, Porcine Parvovirus), Type (Aquaculture, Poultry, Companion Animal, Porcine) – 2021 to 2026 7

Veterinary Vaccines Market by Technology (Toxoid, Recombinant, Inactivated), Disease (Rabies, Clostridial Diseases, Swine Pneumonia, Avian Influenza, Porcine Parvovirus), Type (Aquaculture, Poultry, Companion Animal, Porcine) – 2021 to 2026 8

TABLE OF CONTENT

1 Global Veterinary Vaccines Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Veterinary Vaccines Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Veterinary Vaccines Market – Industry Market Entry Scenario
4.1 Regulatory Framework Overview
4.2 New Business and Ease of Doing business index
4.3 Case studies of successful ventures
4.4 Customer Analysis – Top 10 companies

5 Global Veterinary Vaccines Market – Market Forces
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.2 Opportunities
5.2.3 Challenges
5.3 Porters Analysis of Market
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining powers of customers
5.3.3 Threat of new entrants
5.3.4 Rivalry among existing players
5.3.5 Threat of substitutes

6 Global Veterinary Vaccines Market – Strategic Analysis
6.1 Value Chain analysis
6.2 Supplier and distributor analysis (Market share and product dealing strategies)

7 Global Veterinary Vaccines Market – By Type (Market Size – & million/billion)
7.1 Porcine Vaccines
7.2 Poultry Vaccines
7.3 Livestock Vaccines
7.4 Aquaculture Vaccines
7.5 Companion Animal Vaccines
7.6 Others

8 Global Veterinary Vaccines Market – By Disease
8.1 Porcine Diseases
8.2 Poultry Diseases
8.3 Aquaculture Diseases
8.4 Livestock Diseases
8.5 Companion Animal Diseases
8.6 Others

9 Global Veterinary Vaccines Market – By Technology
9.1 Inactivated Vaccines
9.2 Toxoid Vaccines
9.3 Live Attenuated Vaccines
9.4 Recombinant Vaccines
9.5 Other

10 Global Veterinary Vaccines Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Veterinary Vaccines Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Veterinary Vaccines Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Merck Animal Health
12.3 Zoetis
12.4 Hester
12.5 Biogenesis Bago
12.6 Tianjin Ringpu
12.7 Elanco
12.8 Virbac
12.9 Boehringer Ingelheim
12.10 Ceva
12.11 Vetoquinol
12.12 Company 11 & more

13 Global Veterinary Vaccines Market – Appendix
13.1 Sources
13.2 Abbreviations